NPPES file of Aug 9, 2026

Carlos Antonio Diaz-Balzac, M.D., PH.D.

Endocrinology, Diabetes & Metabolism Physician · Rochester, NY

Carlos Antonio Diaz-Balzac, M.D., PH.D. is an endocrinology, diabetes & metabolism physician with a practice address in Rochester, New York, and NPI 1982137709, issued on Apr 7, 2017. Check the license (New York 298643, as entered in NPPES) on the NYS Education Department, Office of the Professions; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2023 and 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1982137709
Name
Carlos Antonio Diaz-Balzac
Credential
M.D., PH.D.
Primary taxonomy
Endocrinology, Diabetes & Metabolism Physician 207RE0101X
License number
298643 NY
Self-reported in NPPES; status is on the state search
Practice location
601 Elmwood Ave Box Med, Rochester, NY 14642
Phone
(585) 275-2874
Enumerated
Apr 7, 2017
Record last updated
May 22, 2020 (not updated in 6 years: call before relying on the address or phone)
Fax
(585) 273-1288
Medicare enrollment
Enrolled (PECOS I20210812002088); accepts Medicare assignment
Medical or professional school
Albert Einstein College Of Medicine Of Yeshiva University, 2017
Telehealth
Offers telehealth (CMS)
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 601 Elmwood Ave Box Med

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Katherine Arden, MDInternal Medicine Physician1538696794
  2. Nicholas Bartell, M.D.Student in an Organized Health Care Education/Training Program1679927446
  3. Mackenzie Both, PAPhysician Assistant1144887308
  4. Christopher DoucetteStudent in an Organized Health Care Education/Training Program1104352723
  5. Eric Heintz, M.D.Infectious Disease Physician1104184209
  6. Marshall Lichtman, M.D.Hematology (Internal Medicine) Physician1982856415

Verify Carlos Antonio Diaz-Balzac in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersNYS Education Department, Office of the Professions
    Search for license 298643
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the New York license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

90% fewer Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024

275 Medicare Part D claims for 50 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 60% of claims.

  1. Carlos Diaz-Balzac275
  2. Specialty average2,630

Most prescribed

  1. Lantus Solostar31 claims
  2. Ozempic29 claims
  3. Trulicity29 claims
  4. Mounjaro20 claims
  5. Levothyroxine Sodium18 claims
  6. Lisinopril16 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 85.1 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

  1. Qualityout of 100 · 30% of the final score79.0
  2. Costout of 100 · 30%39.7
  3. Promoting interoperabilityout of 100 · 25%100.0
  4. Improvement activities40 of 40 points · 15%100.0

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Bills Medicare through one group practice

  1. Endocrine Practice GroupRochester, NY

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Carlos Antonio Diaz-Balzac among 970 endocrinology, diabetes & metabolism physician records in New York

Carlos Antonio Diaz-Balzac, M.D., PH.D. is one of 970 endocrinology, diabetes & metabolism physician records with a practice address in New York. 86% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2017, is newer than 84% of them.

  • NPI issued2017 · 84% of these records are older, 13% newer
  • In a Medicare fileYes · 86% of these records are
  • In the CMS Doctors and Clinicians fileYes · 72% of these records are
  • Graduated2017 · median 2004 among the 694 with a school on file
  • Record last updated2020 · 59% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RE0101X and a New York practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

Endocrinology, Diabetes & Metabolism Physician providers in New York

There are 970 endocrinology, diabetes & metabolism physician records in New York.

The 8 endocrinology, diabetes & metabolism physician records with the nearest ZIP codes

  1. Marilyn Augustine, MDRochester, NY 146421407960966
  2. Laura Calvi, M.D.Rochester, NY 146421780633826
  3. Lindsay Carafone, MDRochester, NY 146421033614912
  4. John Gerich, MDRochester, NY 146421053339051
  5. Benjamin Gigliotti, M.D.Rochester, NY 146421225327489
  6. Stephen Hammes, MD PHDRochester, NY 146421942267331
  7. Inga Harbuz-Miller, M.D.Rochester, NY 146421598109894
  8. Shiara Ortiz-Pujols, MDRochester, NY 146421376719617

Common questions

What is Carlos Antonio Diaz-Balzac, M.D., PH.D.'s NPI number?

Carlos Antonio Diaz-Balzac, M.D., PH.D.'s National Provider Identifier (NPI) is 1982137709, issued on Apr 7, 2017. An NPI identifies a provider in billing; it is not a license.

Where is Carlos Antonio Diaz-Balzac, M.D., PH.D. located?

The NPPES record lists a practice address at 601 Elmwood Ave Box Med, Rochester, NY, 14642. Phone: (585) 275-2874. Providers update this record themselves, so call before visiting.

How can I verify Carlos Antonio Diaz-Balzac, M.D., PH.D.'s license?

NPPES lists New York license number 298643, as entered by the provider. Search the NYS Education Department, Office of the Professions at https://www.op.nysed.gov/services/verifications/online-verification-searches. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Carlos Antonio Diaz-Balzac, M.D., PH.D. prescribe under Medicare Part D?

In 2024, Carlos Antonio Diaz-Balzac, M.D., PH.D. had 275 Medicare Part D claims for 50 beneficiaries; the average among endocrinology, diabetes & metabolism physician prescribers was 2,630. Part D covers Medicare prescriptions only.

What is Carlos Antonio Diaz-Balzac, M.D., PH.D.'s MIPS final score?

The 2023 MIPS final score is 85.1 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.